271 related articles for article (PubMed ID: 25326816)
41. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
[TBL] [Abstract][Full Text] [Related]
42. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.
Diel R; Nienhaus A; Hillemann D; Richter E
Eur Respir J; 2016 Feb; 47(2):575-87. PubMed ID: 26647440
[TBL] [Abstract][Full Text] [Related]
43. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
[TBL] [Abstract][Full Text] [Related]
45. Screening pulmonary tuberculosis suspects in Malawi: testing different strategies.
Harries AD; Kamenya A; Subramanyam VR; Maher D; Squire SB; Wirima JJ; Nyangulu DS; Nunn P
Trans R Soc Trop Med Hyg; 1997; 91(4):416-9. PubMed ID: 9373637
[TBL] [Abstract][Full Text] [Related]
46. Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
Lee HN; Kim JI; Kim YH
PLoS One; 2021; 16(5):e0250616. PubMed ID: 33939723
[TBL] [Abstract][Full Text] [Related]
47. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis.
Singh S; Singh A; Prajapati S; Kabra SK; Lodha R; Mukherjee A; Singh V; Hesseling AC; Grewal HM;
BMC Microbiol; 2015 Sep; 15():191. PubMed ID: 26420261
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
[TBL] [Abstract][Full Text] [Related]
49. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
[TBL] [Abstract][Full Text] [Related]
50. A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru.
Carriquiry G; Otero L; González-Lagos E; Zamudio C; Sánchez E; Nabeta P; Campos M; Echevarría J; Seas C; Gotuzzo E
PLoS One; 2012; 7(9):e44626. PubMed ID: 22970271
[TBL] [Abstract][Full Text] [Related]
51. Yield of interview screening and chest X-ray abnormalities in a tuberculosis prevalence survey.
Hoa NB; Cobelens FG; Sy DN; Nhung NV; Borgdorff MW; Tiemersma EW
Int J Tuberc Lung Dis; 2012 Jun; 16(6):762-7. PubMed ID: 22507287
[TBL] [Abstract][Full Text] [Related]
52. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation.
Reither K; Manyama C; Clowes P; Rachow A; Mapamba D; Steiner A; Ross A; Mfinanga E; Sasamalo M; Nsubuga M; Aloi F; Cirillo D; Jugheli L; Lwilla F
J Infect; 2015 Apr; 70(4):392-9. PubMed ID: 25312863
[TBL] [Abstract][Full Text] [Related]
53. DIAGNOSTIC TEST OF SPUTUM GENEXPERT MTB/RIF FOR SMEAR NEGATIVE PULMONARY TUBERCULOSIS.
Reechaipichitkul W; Phetsuriyawong A; Chaimanee P; Ananta P
Southeast Asian J Trop Med Public Health; 2016 May; 47(3):457-66. PubMed ID: 27405129
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
[TBL] [Abstract][Full Text] [Related]
55. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
57. Improving the diagnosis of pulmonary tuberculosis in HIV-infected individuals in Ho Chi Minh City, Viet Nam.
Nguyen DT; Hung NQ; Giang LT; Dung NH; Lan NT; Lan NN; Yen NT; Bang ND; Ngoc DV; Trinh LT; Beasley RP; Ford CE; Hwang LY; Graviss EA
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1528-34, i. PubMed ID: 22008768
[TBL] [Abstract][Full Text] [Related]
58. The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya.
van Cleeff MR; Kivihya-Ndugga LE; Meme H; Odhiambo JA; Klatser PR
BMC Infect Dis; 2005 Dec; 5():111. PubMed ID: 16343340
[TBL] [Abstract][Full Text] [Related]
59. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
Kendall EA; Schumacher SG; Denkinger CM; Dowdy DW
PLoS Med; 2017 Dec; 14(12):e1002472. PubMed ID: 29240766
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal.
Khadka P; Thapaliya J; Basnet RB; Ghimire GR; Amatya J; Rijal BP
BMC Infect Dis; 2019 Dec; 19(1):1090. PubMed ID: 31888522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
